Drug Database
Back to search

Poland· PL-100516070

Calfos

A calcifediol product containing calcifediolum monohydricum, registered in Poland by Allpharm Sp. z o.o. sp.k.. The same ATC class is registered in 9 of our 19 countries.

ATC A11CC06

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCalfosATCA11CC06REGISTER NO.PL-100516070PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about calcifediolum monohydricumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Calcifediol is registered in 9 of 19 countries.

Countries holding a registration under ATC A11CC06 (calcifediol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search calcifediol products by name

Calcifediol · ATC A11CC06

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Calcifediolum monohydricum
Manufacturer
Allpharm Sp. z o.o. sp.k.
Country
Poland (PL)
ATC code
A11CC06
ATC class
Calcifediol
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991569976
  • gtin
    05909991569983

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

68 interactions on record for calcifediol.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check calcifediol against other medicinesHow interaction checks work

Calcifediol · interactions on record

68 records

  • 10 severe
  • 57 moderate
  • 1 minor

Most severe, free to view

  • ErgocalciferolA11CC01severe
  • DihydrotachysterolA11CC02severe
  • CalcitriolA11CC04severe
  • ColecalciferolA11CC05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Calcifediol in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All calcifediol products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Hidroferol
  • Belgium · Dédrogyl, Defediol
  • Bulgaria · Хидроферол
  • Czechia · Uperold
  • Germany · Dedrogyl, Rayaldee
  • Denmark · Defevix, Rayaldee
  • Estonia · Defevix, Hidrosun
  • Spain · Calcifediol Normogen, Calcifediol Normon
  • Finland · Defevix
  • France · Calcifediol Desma, Calcifediol Gerda
  • United Kingdom (Northern Ireland) · Domnisol
  • Greece · D Ready, Hidroferol
  • Croatia · Defevix, Tryde
  • Hungary · Defevix
  • Ireland · Calcifediol Faes, Dnord
  • Italy · Didrogyl, Hercal
  • Lithuania · Calcifediol Faes, Defevix
  • Luxembourg · Defediol, Hidroferol Hebdomadaire
  • Latvia · Defevix
  • Netherlands · Dediol Wekelijks, Hidroferol
  • Norway · Defevix, Hidrosun
  • Portugal · Dedrogyl, Dvit
  • Romania · Hidroferol
  • Sweden · Defevix, Rayaldee
  • Slovenia · Defevix, Kalcifediol Faes
  • Slovakia · Defevix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1d0385d1-7560-4c43-b2d6-3fd3e9d50e11
GET /v1/drugs/1d0385d1-7560-4c43-b2d6-3fd3e9d50e11?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki miękkie",
  "source": "urpl",
  "strength": "0,266 mg",
  "packaging": "05909991569976 ¦ Rp ¦ 161355\n10 kaps.\n05909991569983 ¦ Rp ¦ 161356\n5 kaps.",
  "substance": "Calcifediolum monohydricum 0.266 mg",
  "common_name": "Calcifediolum monohydricum",
  "pl_product_id": "100516070",
  "pozwolenie_nr": "118/25",
  "auth_procedure": "IR",
  "authorisation_validity": "2030-03-27"
}
API referenceMCP serverPlans

See everything about calcifediol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console